199 related articles for article (PubMed ID: 22722952)
21. Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults.
Maganga E; Smart LR; Kalluvya S; Kataraihya JB; Saleh AM; Obeid L; Downs JA; Fitzgerald DW; Peck RN
PLoS One; 2015; 10(8):e0134410. PubMed ID: 26287742
[TBL] [Abstract][Full Text] [Related]
22. [Diabetes mellitus and high blood pressure over risk in HIV-infected people followed at Souro Sanou University Hospital Day Hospital, Bobo-Dioulasso 2018].
Hema A; Poda A; Tougouma JB; Meda C; Kabore F; Zoungrana J; Kamoule E; Sore I; Bado G; Ouedraogo AS; Sawadogo AB; Millogo A
Rev Epidemiol Sante Publique; 2021 Apr; 69(2):72-77. PubMed ID: 33563493
[TBL] [Abstract][Full Text] [Related]
23. Independent predictors of metabolic syndrome in HIV-infected patients.
Alencastro PR; Fuchs SC; Wolff FH; Ikeda ML; Brandão AB; Barcellos NT
AIDS Patient Care STDS; 2011 Nov; 25(11):627-34. PubMed ID: 21936688
[TBL] [Abstract][Full Text] [Related]
24. [Obesity, high blood pressure, hypercholesterolaemia, and untreated diabetes in HIV-infected and HIV-uninfected Adults in Mbuji-Mayi (Democratic republic of congo)].
Mukeba-Tshialala D; Nachega JB; Mutombo-Tshingwali M; Arendt V; Gilson G; Moutschen M
Bull Soc Pathol Exot; 2017 Dec; 110(5):301-309. PubMed ID: 28623554
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects.
Mykkänen L; Kuusisto J; Pyörälä K; Laakso M
Diabetologia; 1993 Jun; 36(6):553-9. PubMed ID: 8335178
[TBL] [Abstract][Full Text] [Related]
26. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
[TBL] [Abstract][Full Text] [Related]
27. Human Immunodeficiency Virus and Risk of Type 2 Diabetes in a Large Adult Cohort in Jos, Nigeria.
Isa SE; Oche AO; Kang'ombe AR; Okopi JA; Idoko JA; Cuevas LE; Gill GV
Clin Infect Dis; 2016 Sep; 63(6):830-5. PubMed ID: 27307508
[TBL] [Abstract][Full Text] [Related]
28. Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study.
Duncan AD; Goff LM; Peters BS
PLoS One; 2018; 13(3):e0194199. PubMed ID: 29529066
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.
Calza L; Sachs M; Colangeli V; Borderi M; Granozzi B; Malosso P; Comai G; Corradetti V; La Manna G; Viale P
Clin Exp Nephrol; 2019 Nov; 23(11):1272-1279. PubMed ID: 31327092
[TBL] [Abstract][Full Text] [Related]
31. Diabetes in patients with HIV: patient characteristics, management and screening.
Roerink ME; Meijering R; Bosch M; de Galan BE; van Crevel R
Neth J Med; 2015 Aug; 73(7):310-5. PubMed ID: 26314713
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among HIV Positive Patients in Tehran, Iran.
Rasoolinejad M; Najafi E; Hadadi A; Najafi M; Kalantari S; Moradmand-Badie B; Tayeri K; SeyedAlinaghi S
Infect Disord Drug Targets; 2019; 19(3):304-309. PubMed ID: 30039766
[TBL] [Abstract][Full Text] [Related]
33. Incidence and prevalence of type 2 diabetes mellitus with HIV infection in Africa: a systematic review and meta-analysis.
Prioreschi A; Munthali RJ; Soepnel L; Goldstein JA; Micklesfield LK; Aronoff DM; Norris SA
BMJ Open; 2017 Mar; 7(3):e013953. PubMed ID: 28360243
[TBL] [Abstract][Full Text] [Related]
34. HIV and metabolic syndrome: a comparison with the general population.
Bonfanti P; Giannattasio C; Ricci E; Facchetti R; Rosella E; Franzetti M; Cordier L; Pusterla L; Bombelli M; Sega R; Quirino T; Mancia G
J Acquir Immune Defic Syndr; 2007 Aug; 45(4):426-31. PubMed ID: 17514013
[TBL] [Abstract][Full Text] [Related]
35. Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors.
Al-Habori M; Al-Mamari M; Al-Meeri A
Diabetes Res Clin Pract; 2004 Sep; 65(3):275-81. PubMed ID: 15331208
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study.
Ursini F; Russo E; D'Angelo S; Arturi F; Hribal ML; D'Antona L; Bruno C; Tripepi G; Naty S; De Sarro G; Olivieri I; Grembiale RD
Medicine (Baltimore); 2016 Feb; 95(7):e2552. PubMed ID: 26886599
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of obesity and disturbances in glucose homeostasis in HIV-infected subjects and general population - missed diagnoses of diabetes?
Hanttu A; Kauppinen KJ; Kivelä P; Ollgren J; Jousilahti P; Liitsola K; Koponen P; Sutinen J
HIV Med; 2021 Apr; 22(4):244-253. PubMed ID: 33169536
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent.
Zargar AH; Khan AK; Masoodi SR; Laway BA; Wani AI; Bashir MI; Dar FA
Diabetes Res Clin Pract; 2000 Feb; 47(2):135-46. PubMed ID: 10670914
[TBL] [Abstract][Full Text] [Related]
39. The metabolic syndrome in type 2 diabetic subjects in Gorgan, Iran.
Marjani A; Mojerloo M
J Pak Med Assoc; 2011 May; 61(5):458-61. PubMed ID: 22204179
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study.
Garancini MP; Calori G; Ruotolo G; Manara E; Izzo A; Ebbli E; Bozzetti AM; Boari L; Lazzari P; Gallus G
Diabetologia; 1995 Mar; 38(3):306-13. PubMed ID: 7758877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
